Aetna's total medical membership fell by almost a half million people since the start of the year, but the Hartford, Conn.-based health insurer was still able to build revenue.
Pfizer subsidiary Wyeth and the government have finalized a $784.6 million settlement over allegations that Wyeth hid drug discounts to avoid paying Medicaid millions of dollars in rebates.
The latest annual report card on the nation's health shows there's been progress in narrowing the gap in health disparities between blacks and whites, while Hispanics continued to have better outcomes than both.
California's largest medical association is joining the fight against Dignity Health over its refusal to allow a woman to get her tubes tied during a C-section. The lawsuit is one of a number filed by the ACLU over Catholic hospitals' refusals to offer certain types of reproductive care.
The CMS began to answer the many questions about how physicians will get paid under the Medicare Access and CHIP Reauthorization Act. But some stakeholders were immediately dissatisfied with what they saw, and the 963-page rule may have raised as many questions as it answered.
One of the most comprehensive, independent studies of commercial healthcare prices shows that employers and insurers that provide private health coverage pay a lot more for services depending on the state where people live.
The university said it's the biggest gift in the school's history and it will fund the construction of a 270,000 square-foot, six-story neurosciences building at Mission Bay. The donation also will help support a scholars program that allows neuroscience graduate students to purse high-risk...
The outgoing CEO of embattled drugmaker Valeant Pharmaceuticals will tell lawmakers Wednesday that he was "too aggressive" and made mistakes in significantly hiking prices for several critical medicines, according to testimony provided to the Associated Press.
The release of Mayor Bill de Blasio administration's turnaround plan for the municipal hospital system on Tuesday morning raises a simple question, but one that won't be clear for several years: Will it work? One key watchdog is skeptical.
Lawmakers accused drugmaker Valeant Pharmaceuticals of gouging patients to reward Wall Street investors at a hearing Wednesday focused on the embattled drugmaker's pricing tactics.
The Santa Clara, Calif.-based company is attempting to reorganize as sales of personal computers shrink. Intel officials said the company will make investments in products and technologies, such as the cloud, that will foster revenue growth, and drive more profitable mobile and personal computer...
The House Judiciary Committee on Wednesday took an election-year swipe at the nation's growing drug addiction problem, approving federal grants that would bolster state and local efforts against the abuse of opioid painkillers.